AARD

Aardvark Therapeutics, Inc.

Healthcare · Biotechnology

$81.62 sample

-0.48 (-0.58%) 1D

Market cap

$525.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$81.62 -3.89% 3M daily closessample

87.0478.01

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC8-K filed: material event
Sep 28INSInsider buy: 10% owner
Sep 23INSInsider buy: Chief Executive Officer
Sep 15INSInsider buy: Director
Sep 09INSInsider sell: EVP, Operations
Aug 31INSInsider sell: Chief Executive Officer
Aug 20SECForm 144 filed
Aug 13INSInsider sell: EVP, Operations

Sign up to see the real AARD record →

Company facts

SEC EDGAR registration

Name: Aardvark Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +22sample, -100 to +100
Reporting currency: USD

Who is positioning in AARD

sample

Insiders: 28 insider transactions over 90 days, net selling, $408.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 33 funds hold $10.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.4B +8.8% y/y

Q4 2024Q3 2026

Inventory$15.3B +6.3% y/y

Q4 2024Q3 2026

Accounts receivable$12.1B +21.0% y/y

Q4 2024Q3 2026

Total debt$31.8B +13.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $62.6B -0.4% 3M
Sample peer B: $311.9B +11.7% 3M
Sample peer C: $69.6B +11.5% 3M
Sample peer D: $387.4B +6.7% 3M
Sample peer E: $271.2B +4.3% 3M